DUPONT




    2 0 0 2 D ATA B O O K
DUPONT INVESTOR RELATIONS                                         CONTENTS



                      Ann K. M. Gualtieri   ...
SENIOR LEADERS
BOARD OF DIRECTORS



Charles O. Holliday, Jr. *
Chairman of the Board and
Chief Executive Officer

Alain J...
2002 @ A GLANCE

        During 2002, DuPont took a number of significant steps toward                   MARCH
        its...
JUNE                                                                                                        of ceramic and...
CORPORATE FINANCIAL DATA


    Corporate Highlights                                                                       ...
2000                1999                1998

       $28,268             $26,918             $24,767                      ...
CORPORATE FINANCIAL DATA


    Segment Information                                                                        ...
2002                                                              2001
                                                   ...
CORPORATE FINANCIAL DATA


    Consolidated Income Statement                                    2002       2001        200...
December 31

Consolidated Balance Sheet                                 2002       2001       2000        1999            ...
CORPORATE FINANCIAL DATA


     Consolidated Statement of Cash Flows                                          2002       2...
Selected Additional Data                                                                          2002                  20...
CORPORATE FINANCIAL DATA


     Selected Additional Data                                                                  ...
Net Sales Outside the United States as a Percentage of Sales
                                                             ...
CORPORATE FINANCIAL DATA


          Selected Additional Data

            Price and Volume* Change Summary

          Sel...
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
du pont 2002 Data Book
Upcoming SlideShare
Loading in...5
×

du pont 2002 Data Book

4,045

Published on

Published in: Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
4,045
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
51
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "du pont 2002 Data Book"

  1. 1. DUPONT 2 0 0 2 D ATA B O O K
  2. 2. DUPONT INVESTOR RELATIONS CONTENTS Ann K. M. Gualtieri 1 DuPont Leadership Vice President 2 2002 @ a Glance DuPont Investor Relations (302) 774-0583 4 Corporate Financial Data Highlights Segment Information Consolidated Income Statement Raymond G. Anderson Consolidated Balance Sheet Director (302) 774-1125 Consolidated Statement of Cash Flows Selected Additional Data 15 The DuPont Commitment: Safety, Health and the Environment 16 Organizing for Sustainable Growth Joyce A. McGhee Manager 18 Business Segments (302) 774-6088 Agriculture & Nutrition Coatings & Color Technologies Electronic & Communication Technologies Performance Materials Carol A. Wolff Safety & Protection Investor Relations Textiles & Interiors Coordinator (302) 774-9870 Pharmaceuticals Other 44 Major Sites and Principal Products Main Office Number: (302) 774-4994 Fax: (302) 773-2631 Internet: www.dupont.com DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments. The information presented in this book is either included in, or can be calculated from information included in, previously published company reports on Forms 10K and 10Q. Dollars are in millions except per share or where otherwise indicated. Most notes to financial statements are not included. This information is only a summary and should be read in conjunction with the company’s audited consolidated financial statements and “Management’s Discussion and Analysis” located in the 2002 Annual Report on Form 10K filed with the Securities and Exchange Commission. DuPont DATA BOOK is now available on the Web at www.dupont.com. The DuPont Oval Logo, DuPont TM, The miracles of science ® and all products denoted with TM or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. March 17, 2003
  3. 3. SENIOR LEADERS BOARD OF DIRECTORS Charles O. Holliday, Jr. * Chairman of the Board and Chief Executive Officer Alain J. P. Belda * †† Chairman and Chief Executive Officer, Alcoa Inc. Thomas M. Connelly, Jr.v Richard R. Goodmanson v Edward J. Donnelly Diane H. Gulyas Richard H. Brown * Senior Vice President Group Vice President Executive Vice President Group Vice President and Chief Science & DuPont Coatings & & Chief Operating Officer DuPont Electronic Chairman of the Board and Technology Officer Color Technologies & Communication Chief Executive Officer, Technologies Electronic Data Systems Curtis J. Crawford † ††† President and Chief Executive Officer, Onix Microsystems, Inc. Louisa C. Duemling ** Edward B. du Pont ††† Deborah C. Hopkins † Head, Corporate Strategy, John C. Hodgson v Charles O. Holliday, Jr. v John W. Himes W. Donald Johnson Citigroup, Inc. Senior Vice President Executive Vice President Chairman & Chief Group Vice President DuPont Corporate Strategy Executive Officer DuPont Operations Lois D. Juliber * †† & Services Chief Operating Officer, Colgate-Palmolive Company Göran Lindahl * ** Co-Chairman, Nanomix, Inc. Masahisa Naitoh † Executive Vice Chairman, ITOCHU Corporation William K. Reilly ** ††† President and Chief Executive Officer, Ellen J. Kullman George F. MacCormack Steven R. McCracken Howard L. Minigh Aqua International Partners, LP Group Vice President Group Vice President Group Vice President Group Vice President Former Administrator, DuPont Safety DuPont Textiles DuPont Textiles DuPont Agriculture U.S. Environmental Protection Agency & Protection & Interiors & Interiors & Nutrition H. Rodney Sharp, III † †† Charles M. Vest † President, Massachusetts Institute of Technology Board Committees: † Audit †† Compensation ††† Corporate Governance ** Environmental Policy Stacey J. Mobley v Gary M. Pfeiffer v Dennis Zeleny v Craig G. Naylor * Strategic Direction Senior Vice President, Group Vice President Senior Vice President Senior Vice President Chief Administrative DuPont Performance & Chief Financial Officer DuPont Human Officer & General Counsel Materials Resources v Member, Office of the Chief Executive D P 1 U ONT
  4. 4. 2002 @ A GLANCE During 2002, DuPont took a number of significant steps toward MARCH its transformation to a sustainable growth company. In February, DuPont purchased an equity interest in Merrimac Industries, DuPont aligned its 26 business units into five market- and Inc. The companies agreed to work together to better technology-focused Growth Platforms, focusing on four key understand the dynamics of the markets for high-frequency market arenas. DuPont also initiated actions to create a newly electronic components and modules. formed, wholly-owned subsidiary for its textiles businesses, DuPont introduced the first commercial fluoropolymer resins DuPont Textiles Interiors (DTI), with the intent to separate made using proprietary and fundamentally new manufacturing DTI by year-end 2003, market conditions permitting. During technology that replaces water-based polymerization with a 2002 we also continued to strengthen the company’s portfolio process based on supercritical carbon dioxide. with technologies and offerings that are important to our DuPont announced it is part of a five-year effort spearheaded customers – advancing our growth objectives and creating by the Massachusetts Institute of Technology to develop value for our investors. lightweight molecular materials to equip the U.S. soldier of the Earnings recovered dramatically from the prior year’s low future with uniforms and gear that help heal them, shield them levels, putting aside the significant gain in 2001 from the sale of and protect them against chemical and biological warfare. DuPont Pharmaceuticals. This performance places us at the DuPont and Asahi Kasei Corporation established a joint top of the chemical industry and ahead of many leading venture for the production and marketing of acetal (also known companies in other industries. Actions most significantly as POM) copolymer resins in China. impacting our 2002 performance and positioning DuPont to achieve its sustainable growth goals are: APRIL Science continues to play a premier role in s DuPont and Monsanto Company our pursuit of sustainable growth as we announced a broad-reaching business focus research priorities and assets agreement that gives both companies specifically on addressing unmet customer cross-licenses to enabling technologies. needs in four key market spaces – Both companies dismissed all pending biotechnology, electronics, materials lawsuits, fully resolving a number of science, and safety security. This focus is important business and patent disputes the underpinning for the Growth Platforms. between them. Knowledge Intensity supports more growth s DuPont extended its fuel cells product as we expand offerings across our platforms line beyond Nafion® membranes to include and into our markets based on the unique fuel cell components such as membrane knowledge and capabilities of DuPont. electrode assemblies (MEAs). Nafion® Productivity improvements, driven largely by An engineer at s membranes and MEAs are used to manufacture the proton DuPont’s Fuel Cell Six Sigma methodologies, helped us weather exchange membrane fuel cell stack, which is the critical Technology Center a challenging global economy while transactional center of the fuel cell where chemical energy is prepares a catalyst- continuing to improve our competitiveness. converted into electrical energy. coated membrane of Nafion ® for installation Rigorous financial discipline allowed the s The USDA Food Safety and Inspection Service adopted the into a fuel cell. company to maintain its strong balance DuPontTM BAX® system, a genetics-based screening method, sheet, returning about $1.9 billion in cash to shareholders via to detect Listeria monocytogenes in the nation’s meat and dividends and share repurchase, while maintaining flexibility to poultry supply. invest for growth. MAY JANUARY DuPont formed a joint venture with the Henan Luohe Shineway DuPont began a collaborative effort with the United States Industry Group Co., Ltd., and a cooperative agreement with the Conference of Mayors to survey the homeland security needs Zhengzhou government. The joint venture will produce and mar- of civic leaders in more than 1,000 cities across the country. ket soy protein for mainstream consumer foods in the People’s Republic of China and for export to the Asia/Pacific region. FEBRUARY DuPont Canada, Inc. acquired Liqui-Box Corporation, a The first aircraft baggage container, using DuPontTM Kevlar® leading manufacturer of packaging systems for pumpable fiber as an integral component, passed the FAA’s blast resistant food products for institutional applications. The acquisition container test. The container is made by Telair International. complements DuPont’s Enhance flexible packaging systems DuPont completed its previously announced $2.5 billion share for retail operations. repurchase program by repurchasing $470 million worth of DuPont stock in January and February. DaimlerChrysler reduced clearcoat DuPont introduced “Super Solids” ultra-low emissions coating air emissions by 25 technology at the DaimlerChrysler assembly plant in Newark, percent at its Dodge Delaware. The new technology reduces volatile organic Durango assembly emissions of the final protective clear coat by 25 percent and plant in Newark, Delaware, using offers a significant improvement in scratch and mar resistance. “SuperSolids” technology developed by DuPont. 2 D P U ONT
  5. 5. JUNE of ceramic and organic (rigid and flexible) packaging and circuit DuPont announced the materials to the electronics industry. certification of DuPontTM Antron® carpet fibers as DECEMBER Environmentally Preferable The U.S. Federal Trade Commission Products (EPP) by granted approval for a new generic Scientific Certification fiber subclass in recognition of the Systems (SCS). DuPont is unique qualities of T-400, under the the first and only carpet generic name elasterell-p, the latest Chairman and CEO Chad Holliday, surrounded by DuPont employees from fiber manufacturer to innovation to be marketed under the around the world, rings the closing bell at the New York Stock Exchange achieve this certification. DuPontTM Lycra® brand. on the 200th Anniversary of DuPont, July 19, 2002. DuPont reached an DuPont established a commercial agreement to sell the Clysar® shrink film business and seed business in China by forming a joint venture with one of manufacturing assets to the Bemis Company, Inc. China’s largest seed companies, Denghai Seed Group. The JULY joint venture will produce top-performing corn seed for Chinese farmers. DuPont employees marked the company’s 200th anniversary DuPont and Universal Display Corporation agreed to jointly with worldwide events, celebrating two centuries of bringing develop a new generation of soluble OLED materials and “The miracles of science®” to people around the globe. technology. The joint development agreement establishes an AUGUST important intellectual property collaboration aimed at DuPont and RiTdisplay Corporation launched a mass- combining the best elements of both small molecule OLED and solution processible OLED research. production line for next-generation displays. The high-volume manufacturing plant will produce polymer-based OLED (organic light-emitting diode) flat-panel display modules for DuPont. DuPont won several notable awards in 2002: DuPont and China Nuclear Honghua Specialty Gases Company For the second year in a row, ranked Number 1 among formed a joint venture for the manufacture and sale of nitrogen trifluoride (NF3), a key chamber cleaning and etch gas used in chemical companies in the Fortune survey of “America’s semiconductor manufacturing and flat panel displays. Most Admired Companies” Selected as the Chemical Market Sector Leader of the SEPTEMBER Dow Jones Sustainability World Indexes, the first index DuPont acquired the Atofina fluorotelomer surface protection family tracking the financial performance of sustainability- and specialty surfactants business assets. With the driven companies worldwide acquisition, DuPont becomes the largest integrated producer For the fifth consecutive year, named one of “The Most of fluorotelomer-based specialty products for surface Admired Companies in Brazil” by Carta Capital magazine protection applications in North America and Europe. and the InterScience Institute OCTOBER Ranked one of the “100 Best Companies for Working As part of a federally-sponsored research and development Mothers” by Working Mother magazine initiative, DuPont, Sarnoff and Bell Labs agreed to develop new DuPont Electronic Technologies was named one of “50 organic-thin film transistor technology on plastic substrates. Companies to Watch” in the Electronic Industry’s list of DuPont became the first major agricultural seed producer in Movers Shakers of 2002 the U.S. to be accredited by the National Seed Health System. For the fifth consecutive year, named one of “The 50 Best This accreditation authorizes Pioneer to conduct plant Companies for Latinas to Work for in the United States” by health inspections and tests in compliance with international LatinaStyle magazine phytosanitary regulations, which will speed product For the second year in a row, ranked DuPont Iberica the development and the shipment of seed. most reputable chemical company in Spain in a survey by DuPont announced that it is part of a science-based consortium Cinco Dias, a leading economic daily newspaper that will receive $19 million in matching funds from the U.S. 8th Continent, the DuPont-General Mills joint venture, Department of Energy for research leading to an innovative named to Fast Company magazine’s list of “Fast 50” “bio-refinery”– capable of producing ethanol fuel and value- leaders of innovation added chemicals from renewable resources such as corn. Ranked one of the top 50 U.S. companies to work for in the NOVEMBER National Society of Black Engineers’ 13th Annual Employer DuPont acquired ChemFirst, Inc., which included two Preference Survey semiconductor fabrication materials businesses and a Inducted into the American Textile Hall of Fame at the chemical intermediates business. With the acquisition, DuPont American Textile History Museum becomes a leading supplier of integrated circuit fabrication materials – complementing its role as a leading global supplier D P 3 U ONT
  6. 6. CORPORATE FINANCIAL DATA Corporate Highlights 2002 2001 (dollars in millions, except per share) Operating Results Net sales $24,006 $24,726 Reported income from continuing operations 1 1,841 4,328 Reported income from discontinued operations – – Net income (loss) (1,103) 2 4,339 3 Underlying income from continuing operations 2,009 1,251 Depreciation 1,297 1,320 Cash provided by continuing operations 2,053 2,419 Capital expenditures 1,416 1,634 Research and development expense 6 1,264 1,588 Financial Position, Total assets $34,621 $40,319 Year End Working capital 6,363 6,734 Total debt 6,832 6,814 Stockholders’ equity 9,063 14,452 Data Per Common Share Earnings from continuing operations – reported 1, 7 $1.84 $ 4.15 Earnings from discontinued operations – reported 7 – – Earnings 7 $(1.11) 2 $ 4.16 3 Earnings from continuing operations – underlying 7 $2.00 $1.19 Dividends $1.40 $1.40 Market price – year-end close $42.40 $42.51 high-low range $49.80 – $35.02 $49.88 – $32.64 Book value at year-end $8.88 $14.20 Average number of shares (millions) – diluted 999 1,041 Shares outstanding – year-end (millions) 994 1,002 Ratios Total stockholder return 3.0% (9.1)% Dividend yield 8 3.3% 3.3% Share price increase (decrease) (0.3)% (12.0)% P/E on underlying income from continuing operations 8 21 36 Dividend payout, as percentage of: Underlying earnings per share from continuing operations 70% 117% Cash provided by continuing operations per share 68% 60.3% Cash provided by continuing operations per share 7 $2.06 $2.32 Return on average stockholders’ equity – underlying 17.4% 9.4% Return on average investors’ capital – underlying 9 10.6% 6.8% Cash provided by continuing operations as percentage of total debt 59.4% 10 35.5% Debt to total capital 37.3% 28.8% Current ratio 1.9 1.8 Employees Number of employees – year-end (thousands) 11 79 79 1 Before extraordinary item and cumulative effect of changes in accounting principles. 2 Includes a cumulative effect of a change in accounting principle charge of $2,944 and $2.95 per share (diluted). 3 Includes a cumulative effect of a change in accounting principle benefit of $11 and $.01 per share (diluted). 4 Includes an extraordinary charge from early extinguishment of debt of $201 and $.18 per share (diluted), net of taxes. 5 Includes strategic acquisitions of $4,905 and $3,177 in 1999 and 1998, respectively. 6 Excludes purchased in-process research and development. 7 Diluted, based on average number of common shares. 8 Based on year-end share price. 9 Proforma return on average investors’ capital reflecting the impact of the Conoco split-off on stockholders’ equity and debt equals 16% for 1999, and averaged 17% for 1995 to 1998. 10 Ratio excludes increase in tax payments related to sale of DuPont Pharmaceuticals. 11 Includes employees of discontinued Conoco operations prior to 1999. Throughout the DATA BOOK, the term “underlying” refers to the stated financial measure, excluding the effect of special items. For a list of special items, see page 15 of the 2002 Annual Report on Form 10K. Management believes that an analysis of earnings before special items is particularly meaningful to investors because it provides insight with respect to ongoing operating results of the company and allows readers of the financial statements to better evaluate the financial results of each segment. Special items represent transactions or events that give rise to significant gains or losses that are either unusual to the company’s normal operations or occur infrequently. Underlying income, underlying earnings per share, and underlying segment after-tax operating income are not measurements recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures of performance may be inconsistent with similar measures presented by other companies. 4 D P U ONT
  7. 7. 2000 1999 1998 $28,268 $26,918 $24,767 Dividends Per Share Earnings Per Share – Diluted 2,314 219 1,648 Continuing Operations Before Special Items – 7,471 3,033 (dollars) (dollars) 2,314 7,690 4,480 4 $1.50 $3.00 2,878 2,843 2,913 1,415 1,444 1,452 $2.50 5,070 4,840 4,132 $1.25 $2.00 2,022 6,988 5 5,480 5 1,776 1,617 1,308 $1.50 $39,426 $40,777 $38,536 $1.00 $1.00 2,401 1,425 (2,374) $0.50 9,905 11,566 11,124 13,299 12,875 13,954 1998 1999 2000 2001 2002 1998 1999 2000 2001 2002 $2.19 $0.19 $1.43 – $6.80 $2.65 $2.19 $6.99 $3.90 4 $2.73 $2.58 $2.55 $1.40 $1.40 $1.365 $48.31 $65.88 $53.06 $74.00 – $38.19 $75.19 – $50.06 $84.44 – $51.69 Five-Year Performance 1998– 2002 $12.57 $12.09 $12.18 1,051 1,098 1,145 Stockholder Return DuPont SP 500 1,039 1,045 1,126 Dividend Yield 2.8% 1.4% (24.5)% 26.8% (9.4)% 2.9% 2.1% 2.6% Share Price Annual Appreciation (6.7)% (1.9)% (26.7)% 24.1% (11.7)% 18 26 21 Total Annual Return* (4.1)% (0.6)% Dividend Growth 2.6% 0.7% 51% 53% 53% 29% 31% 37% $4.82 $4.41 $3.61 Ten-Year Performance 1993–2002 21.8% 21.5% 24.2% 13.8% 13.4% 12.4% Stockholder Return DuPont SP 500 51.2% 41.8% 37% 42% 46.3% 43% Dividend Yield 2.8% 1.8% 1.3 1.1 0.8 Share Price Annual Appreciation 6.1% 7.3% 93 94 101 Total Annual Return* 9.1% 9.3% Dividend Growth 4.9% 2.6% * Assumes a steady compounded rate of return over the period shown and includes reinvestment of dividends. D P 5 U ONT
  8. 8. CORPORATE FINANCIAL DATA Segment Information 2002 2001 2000 (dollars in millions) Segment Sales 1 Agriculture Nutrition $ 4,510 $ 4,290 $ 4,467 Coatings Color Technologies 5,026 4,917 5,457 Electronic Communication Technologies 2,540 2,688 3,375 Performance Materials 4,868 4,693 5,334 Pharmaceuticals – 902 1,487 Safety Protection 3,483 3,574 3,694 Textiles Interiors 6,279 6,477 7,722 Other 22 148 141 Total segment sales 26,728 27,689 31,677 Elimination of transfers (375) (480) (642) Elimination of equity affiliate sales (2,351) (2,493) (2,773) Miscellaneous 4 10 6 Net sales per Consolidated Financial Statements $24,006 $24,726 $28,268 Segment After-Tax Operating Income – Underlying Agriculture Nutrition $ 427 $ 246 $ 331 Coatings Color Technologies 525 498 783 Electronic Communication Technologies 216 283 581 Performance Materials 423 277 578 Pharmaceuticals 290 58 133 Safety Protection 487 485 593 Textiles Interiors 216 70 709 Other (85) (58) (31) Total segment after-tax operating income – underlying 2,499 1,859 3,677 (116) (311) (493) Interest and exchange gain (losses) Corporate expenses (333) (281) (306) Corporate minority interest 2 (41) (16) – Underlying income 2,009 1,251 2,878 Net special items 3 (168) 3,077 (564) Reported income 4 $ 1,841 $ 4,328 $ 2,314 1 Sales include transfers and pro rata equity affiliate sales. 2 Represents a rate of return to minority interest investors who made capital contributions during 2001 to consolidated subsidiaries. 3 For complete details of special items, see the DuPont 2002 Form 10-K. 4 Before cumulative effect of changes in accounting principles. DuPont’s Share of DuPont’s Share of Equity Affiliate Sales Equity Affiliate Earnings 2002 2001 2000 2002 2001 2000 Equity Affiliate Analysis Agriculture Nutrition $ 176 $ 188 $ 190 $ (6) $ (13) $ (13) Coatings Color Technologies 109 127 159 (3) (6) 1 Electronic Communication Technologies 212 251 279 10 11 46 Performance Materials 1,073 1,024 1,236 33 (16) 85 Safety Protection 55 89 115 10 10 11 Textiles Interiors 726 814 789 (4) (33) 73 Other – – 5 – – (5) Total segments $2,351 $2,493 $2,773 $ 40 $ (47) $ 198 6 D P U ONT
  9. 9. 2002 2001 1st 2nd 3rd 4th Full Yr. 1st 2nd 3rd 4th Full Yr. Segment Sales 1 Agriculture Nutrition $ 1,605 $ 1,556 $ 608 $ 741 $ 4,510 $ 1,543 $ 1,517 $ 542 $ 688 $ 4,290 Coatings Color Technologies 1,137 1,312 1,276 1,301 5,026 1,205 1,292 1,206 1,214 4,917 Electronic Communication Technologies 578 682 645 635 2,540 784 724 614 566 2,688 Performance Materials 1,152 1,278 1,237 1,201 4,868 1,207 1,215 1,149 1,122 4,693 Pharmaceuticals – – – – – 205 304 393 – 902 Safety Protection 828 894 853 908 3,483 965 937 858 814 3,574 Textiles Interiors 1,450 1,695 1,582 1,552 6,279 1,697 1,742 1,553 1,485 6,477 Other 8 2 6 6 22 29 38 39 42 148 Total segment sales $ 6,758 $ 7,419 $ 6,207 $ 6,344 $26,728 $ 7,635 $ 7,769 $ 6,354 $ 5,931 $27,689 Segment After-Tax Operating Income – Underlying Agriculture Nutrition $ 323 $ 286 $ (99) $ (83) $ 427 $ 256 $ 204 $ (127) $ (87) $ 246 Coatings Color Technologies 85 136 168 136 525 140 118 112 128 498 Electronic Communication Technologies 45 57 66 48 216 115 68 51 49 283 Performance Materials 85 126 127 85 423 95 48 58 76 277 Pharmaceuticals 51 60 72 107 290 (64) 10 84 28 58 Safety Protection 103 119 125 140 487 132 130 112 111 485 Textiles Interiors 29 91 60 36 216 64 7 10 (11) 70 Other (20) (22) (19) (24) (85) (4) 4 (16) (42) (58) Total segment after-tax operating income – underlying 701 853 500 445 2,499 734 589 284 252 1,859 Interest and exchange gain (losses) (59) (50) (5) (2) (116) (97) (88) (72) (54) (311) Corporate expenses (78) (84) (83) (88) (333) (70) (69) (76) (66) (281) Corporate minority interest 2 (12) (8) (11) (10) (41) – – (8) (8) (16) Underlying Income 552 711 401 345 2,009 567 432 128 124 1,251 After-Tax Impact of Special Items 3 Employee separation costs and write-down of assets 19 (197) 17 (39) (200) – (679) – (26) (705) Gain on asset sales – 12 51 27 90 – – 49 3,817 3,866 Pioneer acquisition related costs – – – 67 67 (83) – – – (83) Litigation costs – (31) – (50) (81) – – (35) – (35) Other (92) 48 – – (44) – 34 – – 34 Net impact of special items (73) (168) 68 5 (168) (83) (645) 14 3,791 3,077 Reported income 4 $ 479 $ 543 $ 469 $ 350 $ 1,841 $ 484 $ (213) $ 142 $ 3,915 $ 4,328 2002 2001 1st 2nd 3rd 4th Full Yr. 1st 2nd 3rd 4th Full Yr. Earnings Per Share of Common Stock – Diluted 4, 5 Underlying earnings $ 0.55 $ 0.71 $ 0.40 $ 0.34 $ 2.00 $ 0.54 $ 0.41 $ 0.12 $ 0.12 $ 1.19 Special items (0.07) (0.17) 0.07 0.01 (0.16) (0.08) (0.62) 0.01 3.70 2.96 Reported earnings $ 0.48 $ 0.54 $ 0.47 $ 0.35 $ 1.84 $ 0.46 $ (0.21) $ 0.13 $ 3.82 $ 4.15 1 Sales include transfers and pro rata equity affiliate sales. 2 Represents a rate of return to minority interest investors who made capital contributions during 2001 to consolidated subsidiaries. 3 For complete details of special items and income adjusted for special items, see the DuPont quarterly earnings releases. 4 Before cumulative effect of changes in accounting principles. 5 Earnings per share for the year does not equal to sum of quarterly earnings per share due to changes in average share calculations. D P 7 U ONT
  10. 10. CORPORATE FINANCIAL DATA Consolidated Income Statement 2002 2001 2000 1999 1998 (dollars in millions, except per share) Net sales $24,006 $24,726 $28,268 $26,918 $24,767 Other income 1 516 644 934 974 981 Total 24,522 25,370 29,202 27,892 25,748 Cost of goods sold and other operating charges 16,296 16,727 18,207 16,991 15,556 Selling, general and administrative expenses 2,699 2,925 3,041 2,595 2,115 Depreciation 1,297 1,320 1,415 1,444 1,452 Amortization of goodwill and other intangible assets 218 434 445 246 108 Research and development expense 1,264 1,588 1,776 1,617 1,308 Interest expense 359 590 810 535 520 Purchased in-process research and development – – (11) 2,250 1,443 Employee separation costs and write-down of assets 290 1,078 101 524 633 Gain on sale of DuPont Pharmaceuticals (25) (6,136) – – – Gain on issuance of stock by affiliates – nonoperating – – (29) – – Total 22,398 18,526 25,755 26,202 23,135 Income from continuing operations before income taxes and minority interests 2,124 6,844 3,447 1,690 2,613 Provision for income taxes 185 2,467 1,072 1,410 941 Minority interests in earnings of consolidated subsidiaries 98 49 61 61 24 Income from continuing operations 1,841 4,328 2,314 219 1,648 Discontinued operations Income from operations of discontinued business, net of taxes – – – – 594 Gain on disposal of discontinued business, net of taxes – – – 7,471 2,439 Income before extraordinary item and cumulative effect of changes in accounting principles 1,841 4,328 2,314 7,690 4,681 Extraordinary charge from early extinguishment of debt, net of taxes – – – – (201) Cumulative effect of changes in accounting principles, net of taxes (2,944) 11 – – – Net income (loss) $ (1,103) $ 4,339 $ 2,314 $ 7,690 $ 4,480 Diluted earnings (loss) per share of common stock Continuing operations before extraordinary item and cumulative effect of changes in accounting principles $ 1.84 $ 4.15 $ 2.19 $ .19 $ 1.43 Discontinued operations – – – 6.80 2.65 Before extraordinary item and cumulative effect of changes in accounting principles 1.84 4.15 2.19 6.99 4.08 Extraordinary charge – – – – (.18) Cumulative effect of changes in accounting principles (2.95) .01 – – – Net income (loss) $ (1.11) $ 4.16 $ 2.19 $ 6.99 $ 3.90 1 Other Income: Royalty income $ 128 $ 155 $ 160 $ 127 $ 102 Interest income, net of miscellaneous interest expense 97 146 168 185 112 Equity in earnings (losses) of affiliates 36 (43) 289 135 278 Gains (losses) on sales of assets 30 47 394 16 375 Exchange gains (losses) (294) (29) (35) (107) (22) Cozaar ®/Hyzaar ® income 469 321 92 87 18 Miscellaneous income and expenses – net 50 47 (134) 531 118 Total Other Income $ 516 $ 644 $ 934 $ 974 $ 981 8 D P U ONT
  11. 11. December 31 Consolidated Balance Sheet 2002 2001 2000 1999 1998 (dollars in millions) Assets Current assets Cash and cash equivalents $ 3,678 $ 5,763 $ 1,540 $ 1,466 $ 1,059 Marketable debt securities 465 85 77 116 10 Accounts and notes receivable 3,884 3,903 4,552 5,318 4,201 Inventories 4,409 4,215 4,658 5,057 3,129 Prepaid expenses 175 217 228 202 192 Income taxes 848 618 601 494 645 Total current assets 13,459 14,801 11,656 12,653 9,236 Property, plant and equipment 33,732 33,778 34,650 35,416 34,728 Less: accumulated depreciation 20,446 20,491 20,468 20,545 20,597 Net property, plant and equipment 13,286 13,287 14,182 14,871 14,131 Goodwill 1,167 3,746 3,935 3,900 317 Other intangible assets 3,109 3,151 4,430 4,824 2,249 Investment in affiliates 2,047 2,045 2,206 1,459 1,796 Other assets 1,553 3,289 3,017 3,070 2,390 Net assets of discontinued operations – – – – 8,417 Total $34,621 $40,319 $39,426 $40,777 $38,536 Liabilities and Stockholders’ Equity Current liabilities Accounts payable $ 2,727 $ 2,219 $ 2,731 $ 2,780 $ 1,929 Short-term borrowings and capital lease obligations 1,185 1,464 3,247 4,941 6,629 Income taxes 47 1,295 250 359 130 Other accrued liabilities 3,137 3,089 3,027 3,148 2,922 Total current liabilities 7,096 8,067 9,255 11,228 11,610 Long-term borrowings and capital lease obligations 5,647 5,350 6,658 6,625 4,495 Other liabilities 8,770 7,336 7,729 7,872 7,640 Deferred income taxes 1,622 2,690 2,105 1,660 430 Total liabilities 23,135 23,443 25,747 27,385 24,175 Minority interests 2,423 2,424 380 517 407 Stockholders’ equity 9,063 14,452 13,299 12,875 13,954 Total $34,621 $40,319 $39,426 $40,777 $38,536 D P 9 U ONT
  12. 12. CORPORATE FINANCIAL DATA Consolidated Statement of Cash Flows 2002 2001 2000 1999 1998 (dollars in millions) Cash provided by continuing operations Net income (loss) $(1,103) $ 4,339 $ 2,314 $ 7,690 $ 4,480 Adjustments to reconcile net income to cash provided by continuing operations: Net income from discontinued operations – – – (7,471) (3,033) Extraordinary charge from early retirement of debt – – – – 275 Cumulative effect of changes in accounting principles 2,944 (11) – – – Depreciation 1,297 1,320 1,415 1,444 1,452 Amortization of goodwill and other intangible assets 218 434 445 246 108 Purchased in-process research and development – – (11) 2,250 1,443 Gain on sale of DuPont Pharmaceuticals (25) (6,136) – – – Other noncash charges and credits – net 447 965 899 443 (319) Decrease (increase) in operating assets: Accounts and notes receivable 468 435 379 (21) (580) Inventories and other operating assets (476) (362) (727) (384) (74) Increase (decrease) in operating liabilities: Accounts payable and other operating liabilities (106) (634) 87 185 254 Accrued interest and income taxes (1,611) 2,069 269 458 126 Cash provided by continuing operations 2,053 2,419 5,070 4,840 4,132 Investment activities of continuing operations Purchases of property, plant and equipment (1,280) (1,494) (1,925) (2,055) (2,240) Investments in affiliates (136) (140) (97) (48) (63) Payments for businesses (net of cash acquired) (697) (78) (46) (5,073) (3,282) Proceeds from sales of assets 196 253 703 609 946 Net proceeds from sale of DuPont Pharmaceuticals (122) 7,798 – – – Net proceeds from sale of interest in petroleum operations – – – – 4,206 Net decrease (increase) in short-term financial instruments (318) (2) 25 (258) 131 Miscellaneous – net 28 (117) 96 14 124 Cash provided by (used for) investment activities of continuing operations (2,329) 6,220 (1,244) (6,811) (178) Financing activities Dividends paid to stockholders (1,401) (1,460) (1,465) (1,511) (1,549) Net increase (decrease) in short-term (less than 90 days) borrowings 607 (1,588) (95) (3,244) 1,574 Long-term and other borrowings: Receipts 934 904 4,996 8,420 6,335 Payments (1,699) (2,214) (6,574) (5,612) (8,966) Acquisition of treasury stock (470) (1,818) (462) (690) (704) Proceeds from exercise of stock options 34 153 63 168 257 Increase in minority interests – 1,980 – 105 – Cash used for financing activities (1,995) (4,043) (3,537) (2,364) (3,053) Net cash flow from discontinued operations 1 – (110) – 4,475 (568) Effect of exchange rate changes on cash 186 (263) (215) (108) 97 Increase (decrease) in cash and cash equivalents $(2,085) $ 4,223 $ 74 $ 32 $ 430 Cash and cash equivalents at beginning of year 5,763 1,540 1,466 1,434 1,004 Cash and cash equivalents at end of year $ 3,678 $ 5,763 $ 1,540 $ 1,466 $ 1,434 1 Includes payments of direct expenses related to the Conoco divestiture. 10 D P U ONT
  13. 13. Selected Additional Data 2002 2001 2000 1999 (dollars in millions) Effective Income Tax Rate Statutory U.S. federal income tax rate 35.0% 35.0% 35.0% 35.0% International operations, including settlements (19.0) (0.8) (2.8) 4.2 Lower effective tax rate on export sales (2.2) (0.6) (1.7) (2.2) Postemployment costs (2.3) – – – In-process research development* – – – 46.6 Other – net (2.8) 2.4 0.6 (0.2) Effective income tax rate 8.7% 36.0% 31.1% 83.4% * The charge associated with the 1999 Pioneer transaction was not tax effected because the purchase was a stock acquisition rather than an asset purchase. 2002 2001 2000 1999 1998 As a percentage of net sales: Cost of goods sold and other operating charges 68% 68% 64% 63% 63% Selling, general and administrative expenses 11 12 11 10 9 Research and development expense 5 6 6 6 5 Underlying income from continuing operations 8 5 10 11 12 Cash provided by continuing operations 9 10 18 18 17 Interest coverage ratio* 10.0 4.8 6.9 9.8 9.2 * Underlying income from continuing operations before income taxes, plus the sum of interest expense and amortization of capitalized interest less interest income, divided by the sum of interest expense and capitalized interest less interest income. Research and Development Expenditures Amount per Consolidated Income Statement $1,264 $1,588 $1,776 $1,617 $1,308 Breakdown by product area: Polymer Science 43% 32% 30% 36% 47% Health Science – 28 32 29 14 Agricultural Science 40 30 29 26 27 Electronic Materials 11 6 5 5 7 Chemicals 6 4 4 4 5 Total 100% 100% 100% 100% 100% Selected Additional Data Annual Percent Change in Sales Versus Prior Year* 1% (10)% 1% 0% (4)% Portion due to selling prices (3) (2) (1) (3) (2) Portion due to volume and mix* 4 (8) 2 3 (2) Average Manufacturing Capacity Utilization 81% 78% 81% 83% 82% * Percentage changes are calculated using sales adjusted to exclude current-year sales from acquisitions when there are no comparable prior-year sales, and to exclude prior-year sales of businesses that have been divested. D P 11 U ONT
  14. 14. CORPORATE FINANCIAL DATA Selected Additional Data 2002 2001 2000 (dollars in millions, except per share) Financial Results by Quarter Net sales 1st $ 6,142 $ 6,859 $ 7,593 2nd 6,700 6,997 7,914 3rd 5,482 5,641 6,445 4th 5,682 5,229 6,316 Total $24,006 $24,726 $28,268 Underlying income 1st $ 552 $ 567 $ 898 2nd 711 432 949 3rd 401 128 537 4th 345 124 494 Total $ 2,009 $ 1,251 $ 2,878 Underlying earnings per share of common stock – diluted 1st $ .55 $ .54 $ .85 2nd .71 .41 .90 3rd .40 .12 .51 4th .34 .12 .47 Total $ 2.00 $ 1.19 $ 2.73 Geographic Information 2002 2001 2000 Net Net Net Net Net Net Sales* Property Sales* Property Sales* Property North America United States $11,422 $ 8,282 $12,054 $ 8,167 $14,509 $ 8,887 Canada 859 601 918 536 1,074 538 Mexico 546 172 559 164 581 165 Other 64 82 82 85 76 151 Total $12,891 $ 9,137 $13,613 $ 8,952 $16,240 $ 9,741 Europe, Middle East and Africa Germany 1,609 552 1,590 585 1,716 641 France 859 126 929 170 986 181 United Kingdom 626 701 704 709 783 721 Italy 767 27 854 25 915 29 Other 2,451 1,205 2,354 1,243 2,474 1,232 Total $ 6,312 $ 2,611 $ 6,431 $ 2,732 $ 6,874 $ 2,804 Asia Pacific Japan 840 73 906 75 1,023 78 Taiwan 707 582 663 632 809 680 China 681 149 623 133 487 142 Singapore 108 285 110 325 134 345 Other 1,511 126 1,355 127 1,506 126 Total $ 3,847 $ 1,215 $ 3,657 $ 1,292 $ 3,959 $ 1,371 South America Brazil 573 227 576 187 686 123 Argentina 176 73 223 102 243 118 Other 207 23 226 22 266 25 Total $ 956 $ 323 $ 1,025 $ 311 $ 1,195 $ 266 Total $24,006 $13,286 $24,726 $13,287 $28,268 $14,182 * Net sales are attributed to countries based on location of customer. 12 D P U ONT
  15. 15. Net Sales Outside the United States as a Percentage of Sales 2002 2001 2000 Agriculture Nutrition 51% 52% 50% Coatings Color Technologies 61% 61% 59% Electronic Communication Technologies 57% 55% 51% Performance Materials 54% 52% 51% Pharmaceuticals – 34% 27% Safety Protection 39% 38% 36% Textiles Interiors 52% 50% 47% Other 56% 85% 80% Total 53% 51% 49% Exports from the United States 2002 2001 2000 Net sales (dollars in millions) $4,519 $4,673 $5,117 As a percentage of net sales 19% 19% 18% Purchased Materials and Energy Cost Index (1977 = 100; period average) 2002 2001 2000 1999 1998 Basic Materials 156 163 160 164 164 Precious Metals 226 289 324 240 224 Chemicals 172 178 174 157 170 Hydrocarbons 168 183 198 137 128 Energy 270 332 289 218 218 Total Purchased Index 183 200 198 164 168 Total Variable Cost of Goods Top Purchased Energy and Raw Materials Primary Uses Natural gas .......................... Nylon Electricity ...................... Various Paraxylene .................. Polyester Cyclohexane ............... Nylon Butadiene .................... Nylon Titanium ores ................. White Pigments Ethane ............................... Packaging Polymers Precious metals .................. Electronics Organic pigments .................. Performance Coatings Fiberglass ................................. Engineering Polymers Chlorine ........................................ White Pigments D P 13 U ONT
  16. 16. CORPORATE FINANCIAL DATA Selected Additional Data Price and Volume* Change Summary Selling Price and Sales Volume Worldwide Selling Price and Sales Volume Worldwide Percentage Change from Prior Year Indices, 1990 = 100 150 10 145 8 140 135 6 130 4 125 120 2 115 0 110 105 -2 100 -4 95 90 -6 85 80 -8 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Price Volume Price Volume Selling Price % Change from Prior Year Sales Volume % Change from Prior Year* Year Worldwide U.S. Other Regions Year Worldwide U.S. Other Regions 1993 (3) 0 (7) 1993 2 1 2 1994 (1) (1) (2) 1994 9 5 15 1995 5 3 8 1995 4 1 7 1996 (1) 0 (3) 1996 3 3 4 1997 (3) 0 (7) 1997 7 5 10 1998 (2) (1) (2) 1998 (2) (3) (1) 1999 (3) (2) (4) 1999 3 1 6 2000 (1) 1 (3) 2000 2 (2) 6 2001 (2) (1) (4) 2001 (8) (12) (3) 2002 (3) (3) (3) 2002 4 3 4 2002 Selling Price % Change from Prior Year 2002 Sales Volume % Change from Prior Year* Qtr Worldwide U.S. Other Regions Qtr Worldwide U.S. Other Regions 1st (6) (4) (7) 1st (2) (2) (2) 2nd (4) (3) (6) 2nd 5 3 6 3rd (2) (4) 0 3rd 6 5 7 4th 0 (1) 1 4th 7 8 6 Year (3) (3) (3) Year 4 3 4 * Volume percentage changes are calculated using sales adjusted to exclude current-year sales from acquisitions when there are no comparable prior-year sales and to exclude prior-year sales of businesses that have been divested. 14 D P U ONT

×